Further survival analysis revealed that over-expression of VEGF in the NPC tumor tissue was significantly correlated with decreased 5-year survival rate, especially in patients with advanced clinical stage (stages III and IV), the 5-year survival rate in patients with VEGF over-expression was significantly worse than that of patients with VEGF low-expression. The gene discussed is VEGFA; the disease is nasopharyngeal carcinoma.